Haba Laboratories AAQS
The The AAQS of Haba Laboratories (4925.T) as of Oct 20, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
1
YoY
0.00%
Last updated:
Haba Laboratories has a current AAQS of 1.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Haba Laboratories in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Haba Laboratories in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Haba Laboratories AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2019
1.00 JPY
Jan 1, 2020
1.00 JPY
Jan 1, 2021
1.00 JPY
Jan 1, 2022
1.00 JPY
Jan 1, 2023
1.00 JPY
Jan 1, 2024
1.00 JPY
Jan 1, 2025
1.00 JPY
Jan 1, 2026
1.00 JPY
| YEAR | AAQS | YoY |
|---|---|---|
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Haba Laboratories Stock analysis
What does Haba Laboratories do? HABA Laboratories, Inc. generates revenue through the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products via wholesale to department stores and through mail order services to general customers, while also selling directly at its own retail stores. Its main business focuses on women's and men's cosmetics, targeting consumers seeking natural beauty and health solutions through both retail and direct channels.
The firm's revenue streams include wholesale distribution to retailers and wholesalers, alongside direct sales at its retail stores. Products are marketed under the HABA brand, with a focus on natural ingredients for cosmetics, quasi-drugs, and nutritional supplements. The company serves both individual consumers through mail order and business clients through wholesale partnerships.
HABA Laboratories' business model relies on a dual approach of B2B and B2C sales, with department stores, retailers, and wholesalers as key wholesale partners. The company's product portfolio caters to the growing demand for natural personal care items, leveraging its retail presence and mail order services to reach a broad customer base. Haba Laboratories is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Haba Laboratories stock
The AAQS of Haba Laboratories is 1 in 2026.
On Eulerpool you can find the complete historical development of The AAQS Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Haba Laboratories
All Key Metrics — Haba Laboratories
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth